Ftse Mib
36.443,38
0,04%
DAX
21.732,05
0,01%
S&P 500
6.109,02
0,62%
NASDAQ
19.916,21
1,19%
Bitcoin
104.827,11
0,09%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Panbela Therapeutics Inc (PBLA) Panbela Therapeutics Inc (PBLA) Notizie

Panbela Therapeutics Inc

PBLA
1,11
0,00 (0,00%)
Ultimo aggiornamento: 01:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/9/202414:00GLOBEFirst Patient Enrolled in Phase I Program in STK11 Mutant..
16/8/202423:25EDGAR2Form S-1/A - General form for registration of securities..
13/8/202422:10GLOBEPanbela Provides Business Update and Reports Q2 2024..
30/7/202423:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
30/7/202422:59EDGAR2Form 8-K - Current report
03/7/202422:46EDGAR2Form 8-K - Current report
24/6/202414:00GLOBEPanbela Therapeutics Announces Third Independent Safety..
10/6/202414:00GLOBEPanbela Announces Oral Presentation at Digestive Disease..
29/5/202413:00EDGAR2Form 8-K - Current report
15/5/202422:10GLOBEPanbela Provides Business Update and Reports Q1 2024..
06/5/202414:00GLOBEPanbela Announces Issuance of New Patent in the US and..
01/5/202422:15GLOBEPanbela to Host First Quarter 2024 Earnings Conference Call..
30/4/202414:00GLOBEAcceptance of Eflornithine (DFMO) Abstract for Oral..
26/4/202422:39EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
25/4/202422:36EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
25/4/202422:35EDGAR2Form 8-K - Current report
25/4/202415:09EDGAR2Form 25-NSE - Notification filed by national security..
22/4/202414:02EDGAR2Form 8-K - Current report
22/4/202414:00GLOBEPanbela Therapeutics Announces Interim Data Analysis for..
18/4/202422:31EDGAR2Form S-1 - General form for registration of securities under..
18/4/202414:00GLOBEPanbela Announces Poster Presentation at American..
17/4/202414:36EDGAR2Form 8-K - Current report
17/4/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
16/4/202423:29GLOBEPanbela Announces Transfer to OTCQB Market
04/4/202422:17EDGAR2Form DEF 14A - Other definitive proxy statements
29/3/202422:24EDGAR2Form S-1 - General form for registration of securities under..
29/3/202422:08EDGAR2Form POS AM - Post-Effective amendments for registration..
26/3/202421:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/3/202421:12EDGAR2Form 8-K - Current report
26/3/202421:10GLOBEPanbela Provides Business Update and Reports Q4 and FY 2024..
26/3/202412:21IHMARKETNEWSU.S. Index Futures on the Rise, Oil Prices Show Stability
25/3/202421:15EDGAR2Form PRE 14A - Other preliminary proxy statements
12/3/202421:15GLOBEPanbela to Host Fourth Quarter and Year End 2023 Earnings..
07/3/202412:01EDGAR2Form 8-K - Current report
15/2/202414:05EDGAR2Form 8-K - Current report
15/2/202414:00GLOBEPanbela Regains Compliance with Nasdaq Listing Standards for..
14/2/202402:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202423:24EDGAR2Form 8-K - Current report
01/2/202413:15EDGAR2Form 8-K - Current report
01/2/202413:00GLOBEPanbela Announces Closing of Approximately $9.0 Million..
Apertura: Min: Max:
Chiusura: 1,11

La tua Cronologia

NASDAQ
PBLA
Panbela Therapeutics
BIT
I10525
IT0005616690 20250303 15.5
BITMOT
859969
World Bank Sustainable T...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci